Cargando…
Co-existence of myeloproliferative neoplasias and β-thalassemia with IVS-2-654 mutation—a case report
Thalassemia and myeloproliferative neoplasias (MPNs) are recognized as two separate diseases. Thalassemia is a hemolytic disease caused by abnormal goblin genes, which results in the deficiency of globin chains. MPNs are clonal hematopoietic stem cell diseases characterized by the proliferation of m...
Autores principales: | Wu, Cai, Zhang, Xuewu, Ye, Xingnong, Chen, Dan, Jin, Jie, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798331/ https://www.ncbi.nlm.nih.gov/pubmed/35117557 http://dx.doi.org/10.21037/tcr.2020.01.48 |
Ejemplares similares
-
Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
por: Zhang, Haokun, et al.
Publicado: (2022) -
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
por: Xu, Peng, et al.
Publicado: (2015) -
Myeloproliferative neoplasms complicated with β-thalassemia: Two case report
por: Xu, Neng-Wen, et al.
Publicado: (2022) -
Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms
por: Ye, Xingnong, et al.
Publicado: (2017) -
Correction of RNA splicing defect in β(654)-thalassemia mice using CRISPR/Cas9 gene-editing technology
por: Lu, Dan, et al.
Publicado: (2021)